NBR-19199-19997 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-21
Registered in v-safe
2020-12-21
Dose 1 — Pfizer-BioNTech
2020-12-21
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Nausea

Adult check-in
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2020-12-28
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-05
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-11
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-13
Dose 2 — Pfizer-BioNTech
2021-01-13
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work

Adult check-in
2021-01-14
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-01
Survey response — day 14, dose 2
MedDRA: Anaphylactic reaction — Feeling: Good · Be unable to work, Be unable to do your normal daily activities

Free text: Anaphylactic reaction.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2022-01-13
Survey response — 12 months, dose 2
MedDRA: Cough, Fatigue, Headache, Oropharyngeal pain, Pain, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Headache, body ache, fatigue, cough, sore throat, congestion

MedDRA releases: 2024-11 · check-in free text available
2022-01-13
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-14
Call successful
Does not wish to fill out VAERS report

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-21	Pfizer-BioNTech
2	2021-01-13	Pfizer-BioNTech

Call center

2 call center cases

1 successful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 3 — day 14, dose 2

2021-02-01

Symptoms: Anaphylactic reaction.

Release 10 — 12 months, dose 2

2022-01-13

Symptoms: Headache, body ache, fatigue, cough, sore throat, congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anaphylactic reaction	✓	✓	✓
SD	Cough	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pain	·	·	✓
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release